Specific Karo Healthcare AB facility
Patient safety is a priority for Karo Healthcare.
If you are experiencing a medical emergency, dial the emergency telephone number
in your country, or contact your doctor immediately.
Karo Healthcare AB is continuously monitoring the quality, safety and efficacy of our medicinal products, medical devices and cosmetic products to ensure that their benefits outweigh their risks;
If you have a medical-related enquiry or would like to report an adverse event /side effect or other safety information associated with the use of a Karo Healthcare Product or report a Product complaint or any other quality-related issues, please follow below steps.
The medical information provided herein shall not replace professional advice or independent assessment from healthcare professionals. If your enquiry concerns a general medical condition or questions related to a specific treatment regimen; please consult a healthcare professional.
For Medical Information, please contact your local Karo Healthcare office:
|Austria||medinfoAT@karopharma.com||0049 711 699 720 365|
|Bulgaria||MedinfoBG@karopharma.com||+359 2 9156 135|
|Belgium||MedinfoBE@karopharma.com||+32 474 60 70 11|
|Chech Republic||MedinfoCZ@karopharma.com||+420-602 290 022|
|France||MedinfoFR@karopharma.com||+33 1 81 79 38 34|
|Germany||MedinfoDE@Karopharma.com||0049 711 699 720 365|
|Greece||MedinfoGR@karopharma.com||302 105 787 113-4|
|Hungary||MedinfoHU@karopharma.com||36 1 3187160|
|Iceland||MedinfoIS@karopharma.com||5 222 900|
|Latvia||MedinfoLV@karopharma.com||+371 2 9865787|
|Luxemburg||MedinfoLU@karopharma.com||+32 474 60 70 11|
|Netherlands||MedinfoNL@karopharma.com||+32 474 60 70 11|
|Slovakia||MedinfoSK@karopharma.com||+420-602 290 022|
|Switzerland||MedinfoCH@karopharma.com||+41 61 465 70 40|
Please note, we can only respond to Karo Pharma’s product-specific question.
Karo Healthcare’s Global Patient Safety department work continuously with identifying, analysing, monitoring, and reporting potential side-effects or other potential risks on our medicinal products during their entire lifecycle to ensure that the benefit always outweigh the risk. Medicinal products are also monitored by Competent Authorities world-wide.
The purpose of the continuous safety monitoring is to discover any medicine-related problem, such as unexpected adverse events / side effects or changes in frequency of a known adverse events / side effects to continuously increase our knowledge, promote safe and effective use of our medicinal products, and to provide timely information to patients, healthcare professionals and the public
To report an adverse event / side effect/ Other safety information associated with the use of a Karo Medicinal Product, please contact the national Health Authority in the country of your residence, or contact your local Karo Healthcare office, according to below Table I- Local Karo HealthcareOffice- Pharmacovigilance Contacts:
Adverse Event / Side-effect:
An Adverse Event is an untoward medical occurrence or a deterioration of a pre-existing medical condition after or during exposure to a Medicinal Product, regardless if a causal relationship has been assessed or not.
An adverse event can therefore be any unfavourable and unintended sign (e.g. an abnormal laboratory finding or electrocardiogram changes), symptom (e.g. rash, nausea, diarrhoea), or disease (e.g. hypothyroidism, anaemia, psoriasis) temporally associated with the use of a medicinal product, whether or not considered related to the medicinal product.
Other Safety Information we for example collect is Interactions, Off-label use, Overdose and if our Medicinal Product has been used during Pregnancy.
|Austria||PVAT@karopharma.com||0049 711 699 720 365|
|Belgium||PVBE@Karopharma.com||+32 474 60 70 11|
|Bulgaria||PVBG@karopharma.com||+359 2 9156 135|
|Chech Republic||PVCZ@karopharma.com||+420-602 290 022|
|Finland||PVFI@karopharma.com||+358 9 42411468|
|France||PVFR@karopharma.com||+33 1 81 79 38 34|
|Germany||PVDE@karopharma.com||0049 711 699 720 365|
|Greece||PVGR@karopharma.com||302 105 787 113-4|
|Hungary||PVHU@karopharma.com||36 1 3187160|
|Luxemburg||PVLU@karopharma.com||+32 474 60 70 11|
|Netherlands||PVNL@karopharma.com||+32 474 60 70 11|
|Slovakia||PVSK@karopharma.com||+420-602 290 022|
|Sweden||PVSE@karopharma.com||+46 8 124 106 48|
|Switzerland||PVCH@karopharma.com||+41 61 465 70 40|
We are committed to collect, analyse and react upon any new information about the benefits and risks of our Products.
If possible, we may contact you to find out more details or ask for clarification.
In order to handle your request, complaint or adverse event report, it is required according to pharmacovigilance legislation that Karo Healthcare AB (“Karo Healthcare”) register and process the personal data that you have provided to us.
The information you share with us will be protected and kept confidential in line with applicable laws, regulations, local legislations, and Karo Healthcare data protection processes. More detailed information regarding the processing of your personal Information is available at https://www.karohealthcare.com/privacy-policy/
To report a Product Quality Complaint associated with the use of a Karo Product, please contact your nearest pharmacy.
Karo Healthcare AB
103 24 Stockholm
Klara Norra Kyrkogata 33
111 22 Stockholm